EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting

Alexandria A Oviatt iD, Elizabeth G Gibson iD, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff iD

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.3c00346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Alexandria A Oviatt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States. Hauptthemen laut MEDLINE: Acenaphthenes, DNA Topoisomerase IV, Escherichia coli, Heterocyclic Compounds, 3-Ring. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcenaphthenesDNA Topoisomerase IVEscherichia coliHeterocyclic Compounds, 3-RingAmino AcidsAnti-Bacterial AgentsDNA Gyrase

Stichwörter der Autor:innen

DNA cleavageDNA supercoiling/decatenationgepotidacingyrasetopoisomerase IVtriazaacenaphthylene

Substanzen

AcenaphthenesAmino AcidsAnti-Bacterial AgentsDNA GyraseDNA Topoisomerase IVgepotidacinHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
  • Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
  • Infectious Diseases Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.
  • Laboratory of Single Molecule Biophysics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20982, United States.
  • Department of Medicine (Hematology/Oncology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
  • VA Tennessee Valley Healthcare System, Nashville, Tennessee 37212, United States.

ORCID-Profile: Alexandria A Oviatt, Elizabeth G Gibson, Neil Osheroff

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • BLRD VA
  • Intramural NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • U.S. Department of Veterans Affairs
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Oviatt, A. A., Gibson, E. G., Huang, J., Mattern, K., Neuman, K. C., Chan, P. F., & Osheroff, N. (2024). Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.3c00346

Vancouver

Oviatt AA, Gibson EG, Huang J, Mattern K, Neuman KC, Chan PF, et al. Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.3c00346

BibTeX
@article{Oviatt2024,
  author = {Oviatt, Alexandria A and Gibson, Elizabeth G and Huang, Jianzhong and Mattern, Karen and Neuman, Keir C and Chan, Pan F and Osheroff, Neil},
  title = {Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.3c00346}
}
Kostenlos starten →